首页 > 最新文献

Maternal-fetal medicine (Wolters Kluwer Health, Inc.)最新文献

英文 中文
Vaginal Bleeding After Pregnancy: Progesterone Levels and Pregnancy Outcomes in the First Trimester. 妊娠后阴道出血:孕激素水平和妊娠前三个月的结局。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-05-14 DOI: 10.1097/FM9.0000000000000285
Zhuo Ren, Xinping Sun, Zhi Li, Huixia Yang
{"title":"Vaginal Bleeding After Pregnancy: Progesterone Levels and Pregnancy Outcomes in the First Trimester.","authors":"Zhuo Ren, Xinping Sun, Zhi Li, Huixia Yang","doi":"10.1097/FM9.0000000000000285","DOIUrl":"10.1097/FM9.0000000000000285","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"256-257"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Century of Legacy: Charting New Frontiers in Maternal-Fetal Medicine. 一个世纪的遗产:绘制母胎医学的新领域。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-05-23 DOI: 10.1097/FM9.0000000000000293
Hongbo Qi
{"title":"A Century of Legacy: Charting New Frontiers in Maternal-Fetal Medicine.","authors":"Hongbo Qi","doi":"10.1097/FM9.0000000000000293","DOIUrl":"10.1097/FM9.0000000000000293","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"193-194"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Future Perspectives of Obstetric Intensive Care Units in China. 中国产科重症监护病房的发展与未来展望
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-08-05 DOI: 10.1097/FM9.0000000000000307
Fang He, Dunjin Chen
{"title":"Development and Future Perspectives of Obstetric Intensive Care Units in China.","authors":"Fang He, Dunjin Chen","doi":"10.1097/FM9.0000000000000307","DOIUrl":"10.1097/FM9.0000000000000307","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"195-199"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Observation of a Rare Binder Phenotype With Fetal Overgrowth Due to a SPIN4 Mutation. 一种罕见的由SPIN4突变导致胎儿过度生长的粘结剂表型的临床观察。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-07-07 DOI: 10.1097/FM9.0000000000000298
Noopur Chawla, Meenakshi Rajput, Rhea Shriyan, Sumitra Bachani, Aprajita Gupta
{"title":"Clinical Observation of a Rare Binder Phenotype With Fetal Overgrowth Due to a <i>SPIN4</i> Mutation.","authors":"Noopur Chawla, Meenakshi Rajput, Rhea Shriyan, Sumitra Bachani, Aprajita Gupta","doi":"10.1097/FM9.0000000000000298","DOIUrl":"10.1097/FM9.0000000000000298","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"258-259"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dissecting Vasopressor Efficacy in the Management of Maternal Hypotension in Preeclamptic Cesarean Delivery: A Systematic Review of Randomized Controlled Trials. 剖宫产子痫前期产妇低血压治疗中血管升压药物的疗效:随机对照试验的系统评价。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-09-22 DOI: 10.1097/FM9.0000000000000314
Made Favian Budi Gunawan, Cindy Thiovany Soetomo, Richard Richard, Putu Bagus Darmayasa, Arresta Vitasatria Suastika

Objective: To evaluate the safety and effectiveness of intermittent bolus administration of ephedrine, norepinephrine, and phenylephrine in the treatment of maternal hypotension during spinal anesthesia for cesarean sections in preeclamptic women.

Methods: This PRISMA-based systematic review included English random control trails (RCTs) of women with singleton preeclampsia (American College of Obstetricians and Gynecologists (ACOG) criteria) undergoing cesarean delivery with spinal anesthesia, excluding chronic hypertension or systemic disease. Interventions were intermittent bolus phenylephrine, norepinephrine, or ephedrine, with outcomes on maternal hemodynamics, neonatal status, and adverse events. Searches of PubMed, ScienceDirect, Google Scholar, and Cochrane (to December 2024) plus reference screening identified eligible studies. Two reviewers independently selected studies, extracted data, and assessed risk of bias (Cochrane RoB 2.0). Due to heterogeneity in vasopressor regimens and outcome measures, results were synthesized narratively.

Results: Of 2333 records screened, six RCTs (sample sizes 20-166) were included, all in preeclamptic women undergoing cesarean delivery. Overall risk of bias was low. Norepinephrine better preserved maternal hemodynamics than phenylephrine or ephedrine, with higher cardiac output (6.31 ± 1.08 vs. 5.45 ± 1.21 L/min; P = 0.009) and lower uteroplacental resistance (0.04 ± 0.02 vs. 0.06 ± 0.03; P = 0.002). Ephedrine caused higher heart rates (84.9 ± 7.1 vs. 76.6 ± 6.9 bpm; P < 0.05) and more nausea/vomiting. Neonatal umbilical artery pH was higher with norepinephrine or phenylephrine than ephedrine (7.32 ± 0.02 vs. 7.31 ± 0.03; P < 0.050), while Apgar scores did not differ. Adverse events favored norepinephrine, which reduced bradycardia versus phenylephrine (5.1% vs. 20.5%; relative risk (RR) = 0.25; P = 0.042) and tachycardia versus ephedrine (16.1% vs. 36.4%; RR = 0.54; P = 0.020).

Conclusion: Intermittent bolus administration of norepinephrine offers superior maternal cardiac output and neonatal safety, making it optimal for preeclamptic cesarean deliveries. Phenylephrine is effective for blood pressure control but may induce bradycardia, while the use of ephedrine is limited by its association with neonatal acidosis. Tailored vasopressor selection is thus essential for optimal outcomes.

Registration: PROSPERO; CRD42024565007.

目的:评价麻黄素、去甲肾上腺素、苯肾上腺素间歇给药治疗子痫前期剖宫产腰麻产妇低血压的安全性和有效性。方法:这项基于prisma的系统评价纳入了接受脊髓麻醉剖宫产的单胎子痫前期妇女(美国妇产科学院(ACOG)标准)的英文随机对照试验(rct),排除慢性高血压或全身性疾病。干预措施是间歇性地服用苯肾上腺素、去甲肾上腺素或麻黄素,对产妇血流动力学、新生儿状态和不良事件有影响。检索PubMed, ScienceDirect, b谷歌Scholar和Cochrane(截至2024年12月),加上参考筛选,确定了符合条件的研究。两位审稿人独立选择研究、提取数据并评估偏倚风险(Cochrane RoB 2.0)。由于血管加压疗法和结果测量的异质性,结果是叙述性的。结果:在筛选的2333条记录中,包括6项随机对照试验(样本量20-166),均为剖宫产的先兆子痫妇女。总体偏倚风险较低。去甲肾上腺素比苯肾上腺素和麻黄碱能更好地保护母体血流动力学,心输出量更高(6.31±1.08比5.45±1.21 L/min; P = 0.009),子宫胎盘阻力更低(0.04±0.02比0.06±0.03;P = 0.002)。麻黄碱导致心率升高(84.9±7.1比76.6±6.9 bpm; P < 0.05)和恶心/呕吐加重。去甲肾上腺素和苯肾上腺素组新生儿脐动脉pH值高于麻黄素组(7.32±0.02比7.31±0.03;P < 0.050),而Apgar评分差异无统计学意义。不良事件倾向于去甲肾上腺素,与苯肾上腺素相比,去甲肾上腺素可减少心动过缓(5.1%对20.5%;相对危险度(RR) = 0.25;P = 0.042)和心动过速与麻黄碱(16.1%比36.4%;RR = 0.54; P = 0.020)。结论:间歇给药去甲肾上腺素可提高产妇心输出量和新生儿安全性,是子痫前期剖宫产的最佳选择。苯肾上腺素对血压控制有效,但可能引起心动过缓,而麻黄碱的使用因其与新生儿酸中毒有关而受到限制。因此,量身定制的血管加压剂选择对于获得最佳结果至关重要。注册:普洛斯彼罗;CRD42024565007。
{"title":"Dissecting Vasopressor Efficacy in the Management of Maternal Hypotension in Preeclamptic Cesarean Delivery: A Systematic Review of Randomized Controlled Trials.","authors":"Made Favian Budi Gunawan, Cindy Thiovany Soetomo, Richard Richard, Putu Bagus Darmayasa, Arresta Vitasatria Suastika","doi":"10.1097/FM9.0000000000000314","DOIUrl":"10.1097/FM9.0000000000000314","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the safety and effectiveness of intermittent bolus administration of ephedrine, norepinephrine, and phenylephrine in the treatment of maternal hypotension during spinal anesthesia for cesarean sections in preeclamptic women.</p><p><strong>Methods: </strong>This PRISMA-based systematic review included English random control trails (RCTs) of women with singleton preeclampsia (American College of Obstetricians and Gynecologists (ACOG) criteria) undergoing cesarean delivery with spinal anesthesia, excluding chronic hypertension or systemic disease. Interventions were intermittent bolus phenylephrine, norepinephrine, or ephedrine, with outcomes on maternal hemodynamics, neonatal status, and adverse events. Searches of PubMed, ScienceDirect, Google Scholar, and Cochrane (to December 2024) plus reference screening identified eligible studies. Two reviewers independently selected studies, extracted data, and assessed risk of bias (Cochrane RoB 2.0). Due to heterogeneity in vasopressor regimens and outcome measures, results were synthesized narratively.</p><p><strong>Results: </strong>Of 2333 records screened, six RCTs (sample sizes 20-166) were included, all in preeclamptic women undergoing cesarean delivery. Overall risk of bias was low. Norepinephrine better preserved maternal hemodynamics than phenylephrine or ephedrine, with higher cardiac output (6.31 ± 1.08 <i>vs</i>. 5.45 ± 1.21 L/min; <i>P</i> = 0.009) and lower uteroplacental resistance (0.04 ± 0.02 <i>vs</i>. 0.06 ± 0.03; <i>P</i> = 0.002). Ephedrine caused higher heart rates (84.9 ± 7.1 <i>vs</i>. 76.6 ± 6.9 bpm; <i>P</i> < 0.05) and more nausea/vomiting. Neonatal umbilical artery pH was higher with norepinephrine or phenylephrine than ephedrine (7.32 ± 0.02 <i>vs</i>. 7.31 ± 0.03; <i>P</i> < 0.050), while Apgar scores did not differ. Adverse events favored norepinephrine, which reduced bradycardia versus phenylephrine (5.1% <i>vs</i>. 20.5%; relative risk (<i>RR</i>) = 0.25; <i>P</i> = 0.042) and tachycardia versus ephedrine (16.1% <i>vs</i>. 36.4%; <i>RR</i> = 0.54; <i>P</i> = 0.020).</p><p><strong>Conclusion: </strong>Intermittent bolus administration of norepinephrine offers superior maternal cardiac output and neonatal safety, making it optimal for preeclamptic cesarean deliveries. Phenylephrine is effective for blood pressure control but may induce bradycardia, while the use of ephedrine is limited by its association with neonatal acidosis. Tailored vasopressor selection is thus essential for optimal outcomes.</p><p><strong>Registration: </strong>PROSPERO; CRD42024565007.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"234-243"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558338/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Low Molecular Weight Heparin on Early Pregnancy Loss in Women With Polycystic Ovary Syndrome. 低分子肝素对多囊卵巢综合征早期妊娠丢失的影响。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-08-15 DOI: 10.1097/FM9.0000000000000311
Fanglan Luo, Qinsheng Lu, Wei Wei, Yingmei Cen, Yinchun Huang, Shuang Qin, Chunjiao Wei, Gendie E Lash, Li Li

Objective: To evaluate the early pregnancy loss (EPL) rates in women with and without low molecular weight heparin (LMWH) treatment during early pregnancy.

Methods: A retrospective, non-randomized study was conducted at Guangzhou Women and Children's Medical Center between June 2019 and March 2022, involving women diagnosed with polycystic ovary syndrome (PCOS). All participants conceived following standard preconception care and voluntarily chose either the control group or the LMWH intervention group during the first month of pregnancy. The intervention was administered throughout the entire first trimester. Early and final pregnancy outcomes were recorded, with a particular focus on EPL rates. In addition, venous blood samples and clinical data were collected to compare hormonal profiles, blood lipid levels, and anthropometric parameters between the two groups. Statistical analyses included the two-tailed unpaired Student's t-test, Mann-Whitney U test, Chi-square test, and Kaplan-Meier survival analysis. A value of P < 0.050 was considered statistically significant.

Results: Thirty-eight women in the LMWH group and 102 women in the control group were included. The EPL rates in the LMWH and control groups were 5.3% (2/38) and 26.5% (27/102), respectively (χ 2 = 7.582, P = 0.006, odds ratio (OR) = 0.154, 95% confidence interval (CI): 0.035-0.685). The age (P = 0.005), PCOS subtype (P = 0.012), and levels of total cholesterol (P = 0.003), and high-density lipoprotein (P = 0.018) were significantly different between these two groups. Continued follow-up was performed to observe the long-time effects of LMWH treatment in early pregnancy. Seventy-three patients were successfully delivered, 23 patients in the LMWH group and 50 patients in the control group. There was no significant difference between the LMWH and control groups in gestation length, bleeding during delivery, birth weight, gender of the newborn, or mode of delivery. In addition, Kaplan-Meier curve analysis revealed that LMWH treatment may decrease the risk of EPL in PCOS patients in the first trimester (χ 2 = 4.144, P = 0.040).

Conclusion: LMWH treatment during early pregnancy may reduce the EPL rate in women with PCOS.

目的:评价低分子肝素(LMWH)治疗和未治疗的早期妊娠损失(EPL)率。方法:2019年6月至2022年3月在广州妇女儿童医疗中心进行了一项回顾性、非随机研究,纳入了诊断为多囊卵巢综合征(PCOS)的女性。所有参与者都遵循标准的孕前护理,并在怀孕的第一个月自愿选择对照组或低分子肝素干预组。这种干预贯穿于整个妊娠早期。记录早期和最终妊娠结果,特别关注EPL率。此外,收集静脉血样本和临床数据,比较两组之间的激素谱、血脂水平和人体测量参数。统计分析包括双尾非配对学生t检验、Mann-Whitney U检验、卡方检验和Kaplan-Meier生存分析。P < 0.050认为有统计学意义。结果:低分子肝素组38例,对照组102例。低分子肝素组和对照组EPL发生率分别为5.3%(2/38)和26.5% (27/102)(χ 2 = 7.582, P = 0.006,优势比(OR) = 0.154, 95%可信区间(CI): 0.035 ~ 0.685)。两组患者年龄(P = 0.005)、PCOS亚型(P = 0.012)、总胆固醇(P = 0.003)、高密度脂蛋白(P = 0.018)水平差异均有统计学意义。继续随访观察低分子肝素治疗早期妊娠的长期效果。成功分娩73例,低分子肝素组23例,对照组50例。低分子肝素组与对照组在妊娠期、分娩出血、出生体重、新生儿性别、分娩方式等方面均无显著差异。Kaplan-Meier曲线分析显示,低分子肝素治疗可降低PCOS患者妊娠早期发生EPL的风险(χ 2 = 4.144, P = 0.040)。结论:妊娠早期低分子肝素治疗可降低PCOS患者EPL发生率。
{"title":"Effects of Low Molecular Weight Heparin on Early Pregnancy Loss in Women With Polycystic Ovary Syndrome.","authors":"Fanglan Luo, Qinsheng Lu, Wei Wei, Yingmei Cen, Yinchun Huang, Shuang Qin, Chunjiao Wei, Gendie E Lash, Li Li","doi":"10.1097/FM9.0000000000000311","DOIUrl":"10.1097/FM9.0000000000000311","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the early pregnancy loss (EPL) rates in women with and without low molecular weight heparin (LMWH) treatment during early pregnancy.</p><p><strong>Methods: </strong>A retrospective, non-randomized study was conducted at Guangzhou Women and Children's Medical Center between June 2019 and March 2022, involving women diagnosed with polycystic ovary syndrome (PCOS). All participants conceived following standard preconception care and voluntarily chose either the control group or the LMWH intervention group during the first month of pregnancy. The intervention was administered throughout the entire first trimester. Early and final pregnancy outcomes were recorded, with a particular focus on EPL rates. In addition, venous blood samples and clinical data were collected to compare hormonal profiles, blood lipid levels, and anthropometric parameters between the two groups. Statistical analyses included the two-tailed unpaired Student's <i>t</i>-test, Mann-Whitney <i>U</i> test, Chi-square test, and Kaplan-Meier survival analysis. A value of <i>P</i> < 0.050 was considered statistically significant.</p><p><strong>Results: </strong>Thirty-eight women in the LMWH group and 102 women in the control group were included. The EPL rates in the LMWH and control groups were 5.3% (2/38) and 26.5% (27/102), respectively (<i>χ</i> <sup>2</sup> = 7.582, <i>P</i> = 0.006, odds ratio (<i>OR</i>) = 0.154, 95% confidence interval (<i>CI</i>): 0.035-0.685). The age (<i>P</i> = 0.005), PCOS subtype (<i>P</i> = 0.012), and levels of total cholesterol (<i>P</i> = 0.003), and high-density lipoprotein (<i>P</i> = 0.018) were significantly different between these two groups. Continued follow-up was performed to observe the long-time effects of LMWH treatment in early pregnancy. Seventy-three patients were successfully delivered, 23 patients in the LMWH group and 50 patients in the control group. There was no significant difference between the LMWH and control groups in gestation length, bleeding during delivery, birth weight, gender of the newborn, or mode of delivery. In addition, Kaplan-Meier curve analysis revealed that LMWH treatment may decrease the risk of EPL in PCOS patients in the first trimester (<i>χ</i> <sup>2</sup> = 4.144, <i>P</i> = 0.040).</p><p><strong>Conclusion: </strong>LMWH treatment during early pregnancy may reduce the EPL rate in women with PCOS.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"200-207"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicenter Retrospective Evaluation of the Chinese Expert Consensus Scoring System for the Diagnosis of Obstetrical DIC. 中国专家共识评分系统对产科DIC诊断的多中心回顾性评价。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-09-09 DOI: 10.1097/FM9.0000000000000313
Jianjian Cui, Ziyang Liu, Wencong He, Ruifen Su, Ruilin Ma, Hui Tao, Zejun Yang, Lei Sun, Shaoqi Chen, Yanan Li, Zhishan Jin, Yin Zhao

Objective: To evaluate the diagnostic efficacy and clinical application of the Obstetrical Chinese Disseminated Intravascular Coagulation (DIC) Scoring System (OCDSS).

Methods: This study is a retrospective study that collected 1063 cases from Wuhan Union Hospital, Yichang Central People's Hospital, and the Central Hospital of Enshi Tujia and Miao Autonomous Prefecture between July 2017 and June 2024. These cases were divided into DIC and non-DIC groups based on score standard. Diagnosis of DIC, the rate of hysterectomy, neonatal mortality, and severe asphyxia are the main outcome measures. All the laboratory indicators are all determined by clinical laboratory department of the hospital. Data were expressed as mean ± standard deviation or median (interquartile range) and frequencies. Independent sample t-test or non-parametric test were used to compare measurement data, while the chi-square test was used for count data. Receiver operating characteristic (ROC) curve and area under curve (AUC) were used to test the predictive accuracy. Using univariate and multivariate logistic regression analysis to study the high-risk factors. P < 0.050 indicates a statistical significance.

Results: Of 1063 participants in this study, 29 participants (2.73%) were diagnosed with obstetrical DIC by OCDSS score standard, and all the participants were diagnosed as DIC with underlying disease. When the Takao, Clark, and Erez score standard is the "gold standard", the OCDSS score standard always shows good sensitivity and specificity, with all the AUC over 0.75. OCDSS score standard also has better predictive of hysterectomy (68.18%, 91.07%, 0.872), severe neonatal asphyxia and death (79.17%, 75.07%, 0.842) than the other three score standards. All the indicators included in the OCDSS score standard contributed to the DIC diagnosis (all the P < 0.001). The indicators in the DIC group were more abnormal than the non-DIC group (all the P < 0.001).

Conclusion: OCDSS is a first score standard, especially for pregnancies, it considers the underlying disease, clinical symptoms, and laboratory results. This score system shared a good diagnosis performance for DIC in the Chinese population and may help clinicians make timely decisions.

目的:评价中国产科弥散性血管内凝血(DIC)评分系统(OCDSS)的诊断效果及临床应用价值。方法:对2017年7月至2024年6月在武汉市协和医院、宜昌中心人民医院和恩施土家族苗族自治州中心医院就诊的1063例患者进行回顾性研究。根据评分标准分为DIC组和非DIC组。DIC的诊断、子宫切除术率、新生儿死亡率和严重窒息是主要的结局指标。所有化验指标均由医院临床检验科确定。数据以均数±标准差或中位数(四分位间距)和频率表示。计量资料比较采用独立样本t检验或非参数检验,计数资料比较采用卡方检验。采用受试者工作特征(ROC)曲线和曲线下面积(AUC)来检验预测的准确性。采用单因素和多因素logistic回归分析研究高危因素。P < 0.050为差异有统计学意义。结果:本组1063例受试者中,经OCDSS评分标准诊断为产科DIC的29例(2.73%),均为伴有基础疾病的DIC。当Takao、Clark和Erez评分标准为“金标准”时,OCDSS评分标准始终表现出良好的敏感性和特异性,AUC均大于0.75。OCDSS评分标准对子宫切除术(68.18%,91.07%,0.872)、新生儿重度窒息及死亡(79.17%,75.07%,0.842)的预测也优于其他3种评分标准。所有纳入OCDSS评分标准的指标均有助于DIC的诊断(P均< 0.001)。DIC组各项指标明显高于非DIC组(P < 0.001)。结论:OCDSS是一种第一评分标准,特别是对妊娠患者,它考虑了基础疾病、临床症状和实验室结果。该评分系统对中国人群DIC具有良好的诊断效果,可以帮助临床医生及时做出决策。
{"title":"Multicenter Retrospective Evaluation of the Chinese Expert Consensus Scoring System for the Diagnosis of Obstetrical DIC.","authors":"Jianjian Cui, Ziyang Liu, Wencong He, Ruifen Su, Ruilin Ma, Hui Tao, Zejun Yang, Lei Sun, Shaoqi Chen, Yanan Li, Zhishan Jin, Yin Zhao","doi":"10.1097/FM9.0000000000000313","DOIUrl":"10.1097/FM9.0000000000000313","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the diagnostic efficacy and clinical application of the Obstetrical Chinese Disseminated Intravascular Coagulation (DIC) Scoring System (OCDSS).</p><p><strong>Methods: </strong>This study is a retrospective study that collected 1063 cases from Wuhan Union Hospital, Yichang Central People's Hospital, and the Central Hospital of Enshi Tujia and Miao Autonomous Prefecture between July 2017 and June 2024. These cases were divided into DIC and non-DIC groups based on score standard. Diagnosis of DIC, the rate of hysterectomy, neonatal mortality, and severe asphyxia are the main outcome measures. All the laboratory indicators are all determined by clinical laboratory department of the hospital. Data were expressed as mean ± standard deviation or median (interquartile range) and frequencies. Independent sample <i>t</i>-test or non-parametric test were used to compare measurement data, while the chi-square test was used for count data. Receiver operating characteristic (ROC) curve and area under curve (AUC) were used to test the predictive accuracy. Using univariate and multivariate logistic regression analysis to study the high-risk factors. <i>P</i> < 0.050 indicates a statistical significance.</p><p><strong>Results: </strong>Of 1063 participants in this study, 29 participants (2.73%) were diagnosed with obstetrical DIC by OCDSS score standard, and all the participants were diagnosed as DIC with underlying disease. When the Takao, Clark, and Erez score standard is the \"gold standard\", the OCDSS score standard always shows good sensitivity and specificity, with all the AUC over 0.75. OCDSS score standard also has better predictive of hysterectomy (68.18%, 91.07%, 0.872), severe neonatal asphyxia and death (79.17%, 75.07%, 0.842) than the other three score standards. All the indicators included in the OCDSS score standard contributed to the DIC diagnosis (all the <i>P</i> < 0.001). The indicators in the DIC group were more abnormal than the non-DIC group (all the <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>OCDSS is a first score standard, especially for pregnancies, it considers the underlying disease, clinical symptoms, and laboratory results. This score system shared a good diagnosis performance for DIC in the Chinese population and may help clinicians make timely decisions.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"216-227"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum SARS-CoV-2-Specific Antibodies and Neutralization Capacity Following Vaccination. 接种疫苗后血清sars - cov -2特异性抗体和中和能力。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-02-10 DOI: 10.1097/FM9.0000000000000251
Long Nguyen-Hoang, Maran Bw Leung, Hillary Yh Leung, Sakita Moungmaithong, Angela St Tai, Chi Chiu Wang, Wing Cheong Leung, Liona C Poon
{"title":"Serum SARS-CoV-2-Specific Antibodies and Neutralization Capacity Following Vaccination.","authors":"Long Nguyen-Hoang, Maran Bw Leung, Hillary Yh Leung, Sakita Moungmaithong, Angela St Tai, Chi Chiu Wang, Wing Cheong Leung, Liona C Poon","doi":"10.1097/FM9.0000000000000251","DOIUrl":"10.1097/FM9.0000000000000251","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"260-262"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stage IV Pancreatic Adenocarcinoma in Pregnancy. 妊娠期胰腺腺癌。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-08-25 DOI: 10.1097/FM9.0000000000000300
Shelby Masters, Shihyun Kim, Elena Moses, Ashelee Mcmanaman, Bipin Ghimire, Gregory Goyert
{"title":"Stage IV Pancreatic Adenocarcinoma in Pregnancy.","authors":"Shelby Masters, Shihyun Kim, Elena Moses, Ashelee Mcmanaman, Bipin Ghimire, Gregory Goyert","doi":"10.1097/FM9.0000000000000300","DOIUrl":"10.1097/FM9.0000000000000300","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"263-264"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Customized Birthweight Standard for the Population in the Republic of Kazakhstan. 哈萨克斯坦共和国人口出生体重定制标准。
IF 1.7 Pub Date : 2025-10-01 Epub Date: 2025-09-09 DOI: 10.1097/FM9.0000000000000309
Meruyert Sharipova, Gulyash Tanysheva, Khalida Sharipova, Bologan Ion, Aizhan Shakhanova

Objective: To assess the impact of maternal physiological and pathological factors on fetal birth weight in pregnancies in Kazakhstan.

Methods: This retrospective cross-sectional study was conducted from January 2016 to December 2021 at Aksu City Hospital, Atyrau Regional Perinatal Center, Altai Interdistrict Hospital, Abay Regional Perinatal Center of the Health Department, and Astana Multidisciplinary City Hospital No. 3, in the Republic of Kazakhstan using the stratified randomization grouping method. The study involved two maternal ethnicity groups, Asian (5101; 77.91%) and European (1446; 22.09%). All statistical analyses were performed using Stat Tech version 3.0.9 and SPSS 26.0.

Results: This study involved 6547 pregnant women. Fetuses weighing < 2500 g were more common in the Asian group than in the European one (P = 0.001), while large fetuses (> 4000 g) were more common in the European group (P = 0.001). Multiple linear regression analyses revealed that a history of arterial hypertension and preeclampsia leads to decreased fetal weight, while gestational diabetes mellitus (GDM) was associated with increased fetal weight. In the Asian ethnic group, maternal physiological factors and a history of arterial hypertension, preeclampsia, and GDM significantly influenced fetal birth weight. In the European group, a history of hypertension and GDM did not affect birth weight.

Conclusion: Stillbirth and perinatal death were more likely among women of the Asian ethnic group when compared with women of the European ethnic group. Therefore, it is necessary to account for the maternal physiological and pathological factors that may influence fetal birth weight when assessing optimal fetal birth weight.

目的:探讨哈萨克斯坦孕妇生理病理因素对胎儿出生体重的影响。方法:本回顾性横断面研究于2016年1月至2021年12月在哈萨克斯坦共和国阿克苏市医院、阿特劳地区围产期中心、阿尔泰区际医院、卫生部阿贝地区围产期中心和阿斯塔纳多学科城市第三医院进行,采用分层随机分组方法。该研究涉及两个母亲族群,亚洲(5101;77.91%)和欧洲(1446;22.09%)。所有统计分析均使用Stat Tech 3.0.9版和SPSS 26.0进行。结果:本研究涉及6547名孕妇。体重< 2500 g的胎儿在亚洲组比欧洲组多见(P = 0.001),而大胎(> 4000 g)在欧洲组多见(P = 0.001)。多元线性回归分析显示,动脉高血压和先兆子痫病史导致胎儿体重下降,而妊娠期糖尿病(GDM)与胎儿体重增加有关。在亚洲人群中,母亲的生理因素和动脉高血压、先兆子痫和GDM病史显著影响胎儿出生体重。在欧洲组中,高血压病史和GDM对出生体重没有影响。结论:与欧洲族裔妇女相比,亚洲族裔妇女死产和围产期死亡的可能性更大。因此,在评估最佳胎儿出生体重时,有必要考虑可能影响胎儿出生体重的母亲生理和病理因素。
{"title":"Customized Birthweight Standard for the Population in the Republic of Kazakhstan.","authors":"Meruyert Sharipova, Gulyash Tanysheva, Khalida Sharipova, Bologan Ion, Aizhan Shakhanova","doi":"10.1097/FM9.0000000000000309","DOIUrl":"10.1097/FM9.0000000000000309","url":null,"abstract":"<p><strong>Objective: </strong>To assess the impact of maternal physiological and pathological factors on fetal birth weight in pregnancies in Kazakhstan.</p><p><strong>Methods: </strong>This retrospective cross-sectional study was conducted from January 2016 to December 2021 at Aksu City Hospital, Atyrau Regional Perinatal Center, Altai Interdistrict Hospital, Abay Regional Perinatal Center of the Health Department, and Astana Multidisciplinary City Hospital No. 3, in the Republic of Kazakhstan using the stratified randomization grouping method. The study involved two maternal ethnicity groups, Asian (5101; 77.91%) and European (1446; 22.09%). All statistical analyses were performed using Stat Tech version 3.0.9 and SPSS 26.0.</p><p><strong>Results: </strong>This study involved 6547 pregnant women. Fetuses weighing < 2500 g were more common in the Asian group than in the European one (<i>P</i> = 0.001), while large fetuses (> 4000 g) were more common in the European group (<i>P</i> = 0.001). Multiple linear regression analyses revealed that a history of arterial hypertension and preeclampsia leads to decreased fetal weight, while gestational diabetes mellitus (GDM) was associated with increased fetal weight. In the Asian ethnic group, maternal physiological factors and a history of arterial hypertension, preeclampsia, and GDM significantly influenced fetal birth weight. In the European group, a history of hypertension and GDM did not affect birth weight.</p><p><strong>Conclusion: </strong>Stillbirth and perinatal death were more likely among women of the Asian ethnic group when compared with women of the European ethnic group. Therefore, it is necessary to account for the maternal physiological and pathological factors that may influence fetal birth weight when assessing optimal fetal birth weight.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"208-215"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Maternal-fetal medicine (Wolters Kluwer Health, Inc.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1